Case of the month: rivastigmine (Exelon) toxicity with evidence of respiratory depression.

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med (1992) 5.93

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA (1997) 5.09

The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord (1999) 2.30

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Clin Ther (1998) 1.29

Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease. Acta Neurol Scand (1998) 1.09

Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans. J Clin Psychopharmacol (1999) 0.93

Pharmacologic treatments of dementia. Med Clin North Am (2002) 0.86

Pharmacologic and clinicopharmacologic properties of SDZ ENA 713, a centrally selective acetylcholinesterase inhibitor. Ann N Y Acad Sci (1991) 0.86

Treatment of dementia with neurotransmission modulation. Expert Opin Investig Drugs (2003) 0.86

Rivastigmine for Alzheimer's Disease: Improvement Versus Reduced Worsening. Prim Care Companion J Clin Psychiatry (2000) 0.85

A case report of an unusual sternal fracture. Emerg Med J (2005) 0.75